Your browser doesn't support javascript.
loading
C1s Inhibition by BIVV009 (Sutimlimab) Prevents Complement-Enhanced Activation of Autoimmune Human B Cells In Vitro.
Nikitin, Pavel A; Rose, Eileen L; Byun, Tony S; Parry, Graham C; Panicker, Sandip.
  • Nikitin PA; Bioverativ, a Sanofi company, South San Francisco, CA 94080 pavel.nikitin@bioverativ.com.
  • Rose EL; Bioverativ, a Sanofi company, South San Francisco, CA 94080.
  • Byun TS; Bioverativ, a Sanofi company, South San Francisco, CA 94080.
  • Parry GC; Bioverativ, a Sanofi company, South San Francisco, CA 94080.
  • Panicker S; Bioverativ, a Sanofi company, South San Francisco, CA 94080.
J Immunol ; 202(4): 1200-1209, 2019 02 15.
Article en En | MEDLINE | ID: mdl-30635392
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Linfocitos B / Complemento C1s / Anticuerpos Monoclonales Humanizados Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Linfocitos B / Complemento C1s / Anticuerpos Monoclonales Humanizados Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article